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Background: Polyadenylation is a key regulatory step in eukaryotic gene expression and one of the major contributors
of transcriptome diversity. Aberrant polyadenylation often associates with expression defects and leads to human
diseases.
Results: To better understand global polyadenylation regulation, we have developed a polyadenylation sequencing
(PA-seq) approach. By profiling polyadenylation events in 13 human tissues, we found that alternative cleavage and
polyadenylation (APA) is prevalent in both protein-coding and noncoding genes. In addition, APA usage, similar to gene
expression profiling, exhibits tissue-specific signatures and is sufficient for determining tissue origin. A 3′ untranslated
region shortening index (USI) was further developed for genes with tandem APA sites. Strikingly, the results showed
that different tissues exhibit distinct patterns of shortening and/or lengthening of 3′ untranslated regions, suggesting
the intimate involvement of APA in establishing tissue or cell identity.
Conclusions: This study provides a comprehensive resource to uncover regulated polyadenylation events in human
tissues and to characterize the underlying regulatory mechanism.Background
Polyadenylation is a crucial step during the maturation
of pre-messenger RNAs (pre-mRNA) in eukaryotes.
With a few exceptions (e.g., histone), protein coding
transcripts are cleaved at their 3′ ends and subsequently
polyadenylated, resulting in a characteristic poly(A) tail
[1]. While 3′-end processing takes place in nucleus, it
has profound effects on gene expression regulation, in-
cluding transcription termination, terminal intron re-
moval, mRNA export, translation initiation, and mRNA
stability [2-5]. As one of the key regulated steps in mRNA
maturation, improper cleavage and polyadenylation is* Correspondence: tingni@fudan.edu.cn; jun.zhu@nih.gov
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reproduction in any medium, provided the oroften associated with expression defects and lead to
human diseases [6-9].
3′-end formation of nascent transcripts is mediated by
a large multi-protein complex, which in human consti-
tutes of more than 80 proteins [9]. Several key subunits
of this large complex has been characterized, including
the cleavage and polyadenylation specificity factor
(CPSF), cleave stimulation factor (CstF), cleavage factor I
and II (CFIm, CFIIm), and poly(A) polymerase (PAP)
[5]. In mammals, recruitment of the 3′-end processing
complex to pre-mRNAs is mediated by a bipartite
sequence element: CPSF interacts with a conserved
AAUAAA or AUUAAA upstream motif, while CstF rec-
ognizes an U- or GU-rich downstream sequence element
(DSE). Other factors (e.g., CFIIm and PAP) are subse-
quently recruited to form a functional 3′-end processing
complex. Furthermore, additional sequences upstream
(USEs) and/or downstream of the core elements may
also play an auxiliary role in complex assembly and 3′-
end formation [10]. Lastly, it has been shown that nucle-
osomes are preferentially depleted at the polyadenylationThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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be involved in defining authentic 3′-end formation [11].
Polyadenylation is a highly regulated event and alter-
native polyadenylation (APA) is one of the major
contributors of transcriptome diversity [12,13]. Earlier
estimation suggested that approximately half of human
and mouse transcripts (51.25% and 46.97%, respectively)
harbor multiple poly(A) sites, leading to heterogeneous
3′ end formation [14]. A more recent survey showed
that up to 80% of the human genes exhibit tissue-
specific variants resulting from tandem 3′ untranslated
region (3′ UTR) events [12]. Emerging evidence suggests
that APA is coordinated with other regulatory events
(e.g. transcriptional activity, alternative splicing and
miRNA targeting) to ensure robust tissue- or cell-specific
gene expression [8,12,15-18]. 3′ UTR length also plays a
critical role in cell differentiation, proliferation and human
diseases [8,15,16,19,20].
Global understanding of polyadenylation events in
vertebrates has come primarily from cDNAs and
expressed sequence tags [21]. Several genome-wide ap-
proaches have been recently developed based on tilling
array [22] and sequencing based approaches [19,23-32].
Here, we present a modified polyadenylation sequencing
or PA-seq strategy, allowing for precise identification of
polyadenylation site at the genome scale in a cost-
effective manner. By monitoring polyadenylation profiles
of 13 human tissues, tissue-specific APA signatures were
identified. In addition, noncoding transcripts, similar to
protein-coding genes, are extensively regulated at the
polyadenylation level. Lastly, we showed distinct patterns
of 3′ UTR shortening/lengthening among different
tissues, suggesting that APA may play a critical role in
establishing tissue or cell identity. Together, the PA-seq
strategy provided a comprehensive polyadenylation land-
scape of human transcripts across diverse tissues. It can
be broadly employed to monitor polyadenylation profiles
of eukaryotic transcriptomes.
Results
A paired-end sequencing strategy to map global
polyadenylation sites
To reliably monitor genome-wide polyadenylation events,
we developed a modified polyadenylation sequencing
strategy or PA-seq (Figure 1a). Briefly, total RNA is
fragmented and reverse transcribed with a modified oligo
(dT) primer, which contains a dual biotin group at the 5′
end and a dUTP at a fixed location (the 4th base from the
3′ end). After second strand synthesis, the resulting cDNA
fragments are captured using streptavidin-coupled mag-
netic beads. Uracil-Specific Excision Reagent (USER),
which recognizes and specially cleaves at the modified
base (dUTP), is then used to release the cDNA fragments
from beads. The resulting products are further ligated withbarcoded Illumina paired-end adaptors, followed by low-
cycle amplification and Illumina sequencing. Notably, the
USER cleavage removes the long poly(A) stretch in
cDNAs, therefore eliminating the potential complication
due to these low complexity sequences. Lastly, the built-in
strand specificity also allows for reliable detection of PA
sites at complex genomic loci (e.g., convergent transcripts
with overlapping 3′ ends).
PA-seq was employed to monitor polyadenylation
profiles of 13 human tissues, including fetal and adult
brains, breast, colon, heart, kidney, liver, lung, pan-
creas, prostate, skeletal muscle, spleen and testis. We
obtained ~108 million paired 51-mer reads. Of them, 78%
(~84 millions) of the read pairs can be uniquely mapped
to the reference genome (Additional file 1). Another 7% of
reads were mapped to multiple genomic locations, pos-
sibly due to repetitive regions in the human genome. For
downstream data analyses, we focused on polyadenylation
cleavage sites derived from uniquely mapped sequencing
pairs.
As the initial assessment of PA-seq data, we interro-
gated the relative location of experimentally identified
PA sites (all uniquely mapped pairs) in respect to
PolyA_DB annotations [14]. In terms of coverage, ~60%
of all PA sites in the PolyA_DB have concordant reads
observed in our data set (Figure 1b). An additional 18%
of PolyA_DB sites are within 5nt of our PA-seq data
(dashed green line in Figure 1b). Conversely, more than
60% of all uniquely mapped pairs are consistent with PA
sites annotated in PolyA_DB (Figure 1c). We also com-
pared the distance between PA-seq data and RefSeq
annotation, which showed similar concordant results
(Additional file 2). Non-redundant read pairs were also
used to avoid potential biases for highly expressed genes
or due to polymerase chain reaction (PCR) artifacts.
While known PA sites remained as the dominant category,
distal PA sites became more prominent (Additional file 3),
suggesting that novel PA sites remained to be identified. A
representative genomic region with four genes showed
that the majority of the reads overlapped with the anno-
tated PA sites (Figure 1d). Together, these results strongly
suggested that PA-seq is a reliable approach for direct
monitoring of genome-wide polyadenylation events.
To examine whether the PA-seq results reflect relative
gene expression level, the tag counts of individual genes
were compared with the available microarray-based
expression datasets of the same tissue origin. With min-
imal normalization of both the array and the sequence
data, PA-seq and array expression profiles were consid-
erably correlated (R = 0.64, Additional file 4). This result
was comparable with the correlation observed between
typical RNA sequencing (RNA-seq) and array-based
methods [33,34]. PA-seq expression profile was also
correlated with RNA-seq (R = 0.76, Additional file 5).
Figure 1 The PA-seq strategy. (a) Schematic diagram of the PA-seq procedure. Dual-biotin labeled DNA oligo was used for the reverse
transcription. ‘U’ stands for the deoxyuracil. ‘V’ denotes any nucleotide but Thymine and ‘N’ represents any nucleotide. USER (Uracil-Specific
Excision Reagent) enzyme catalyzes the excision of the uracil base in the double-stranded DNA and cleaves the abasic site to form 5′ phosphorylated
(p) end. (b) Overlap between PA sites identified by PA-seq and those annotated in polyA_DB [14]. The background is obtained by permuting the reads
within the same UTRs and then assessing the overlap. (c) Distance between experimentally identified PA cleavage sites and polyA_DB annotations. For
genes with multiple PA sites, the shortest distance was used. (d) A snap view of PA cleavage sites identified by PA-seq. PA sites were separated by plus
(Red) and minus (Blue) strands. Known RefSeq transcripts are shown at the bottom.
Ni et al. BMC Genomics 2013, 14:615 Page 3 of 15
http://www.biomedcentral.com/1471-2164/14/615Therefore, the read count generated with the PA-seq
approach can potentially be used to reflect transcript
abundance.
Prevalent APA in protein-coding and noncoding transcripts
Next, we applied F-seq, a feature density estimator [34,35],
to compute PA cluster based on uniquely mapped read
pairs. The PA-seq data from 13 tissues were combined so
that a unified peak-calling scheme can be applied. To filter
out any potential nonspecific priming events, we removed
PA clusters with 15 or more ‘A’ in the 20 nt region down-
stream of peak mode (the most frequent position in the
cluster). With a minimum of 50 tags, 38,080 discrete PAclusters were identified, which cover 16,435 coding genes
and 1,034 non-coding RNAs (ncRNAs) based on RefSeq
annotation. Overall, there are 28,585 PA clusters within
the protein-coding loci, of which 38% have two or more
PA clusters (Figure 2a,c). Consistent with a previous esti-
mation [14], each coding gene has on average 1.74 PA
clusters. In addition, we identified 1,715 PA clusters cover-
ing 1,034 annotated ncRNAs (or 1.66 PA cluster per
ncRNA), and 35% ncRNAs have two or more PA clusters
(Figure 2c, right panel). These results strongly indicated
that ncRNAs, similar to the coding transcripts, are exten-
sively regulated by alternative polyadenylation. The rest of
the PA clusters (7714, ~20%) are distant (> 500 bp) from
Figure 2 The genomic location of PA clusters identified by PA-seq. (a) The genomic location of all PA clusters identified. The number of PA
clusters for each subcategory is shown. (b) The location of PA clusters in protein-coding genes based on RefSeq annotation. (c) The number of
PA clusters detected for protein-coding genes (left panel) and noncoding RNAs (right panel), respectively. The inset in each panel shows a
representative locus with known annotations as well as PA clusters identified.
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represent distant PA sites of known genes, others are likely
derived from novel transcripts in intergenic regions. The
distribution of these distant PA clusters largely followed
the genome-wide trend (Additional file 6). Furthermore,
we found that majority (~87%) of PA clusters are
employed in 5 or more tissues, including 35.53% of the
clusters that can be detected in all 13 tissues (Additional
file 7). The distribution of the distant PA clusters (7714)
showed a similar trend: majority (~90%) of them are
employed in 5 or more tissues, and 17.92% of the PA
clusters can be detected in all 13 tissues (Additional file 7).
These data suggested that genic and intergenic PA sites
are relatively ubiquitously employed, while a considerable
proportion (10.11 ~ 13.36%) may exhibit tissue-restricted
usage (Additional file 7). Overall, our data serve as a
unique resource to uncover novel PA sites in known genes
and/or novel transcripts.
For the protein-coding PA clusters, their relative loca-
tions within respective genes were determined (Figure 2b).40.3% of the clusters are overlapped with known poly-
adenylation sites, 36.82% and 3.11% clusters are located in
the annotated and extended 3′ UTR regions (500 bp
downstream of the most proximal 3′ PA sites), respect-
ively. These alternative PA sites are expected to modulate
the length of 3′ UTRs and may affect the stability,
localization and/or translation of the corresponding
transcripts [14,23]. In addition, a considerable proportion
(15.26%) of the PA clusters fall into introns, suggesting the
potential coupling of alternative splicing and poly-
adenylation [12]. A small subset of the PA clusters is
mapped to exons (1.81%) as well as the upstream regions
of the transcripts (5′ UTR: 2.5%; transcription start sites:
0.01%; promoter: 0.2%; Figure 2b). These 5′ proximal PA
clusters are interesting and may have resulted from
transcriptional read-through [36], enhancer RNAs [37,38]
or other novel mechanisms [39]. Together, our data
support the notion that 3′-end formation in the human
transcriptomes is much more complex than previously
appreciated [23,30,36].
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Since our data uncovered a large number of novel
polyadenylation sites, RT-PCR was used to experimen-
tally validate novel PA clusters located in the 3′ UTR
and intronic regions (Figure 3; Additional file 8; see
Methods for detail). These PA sites represent two most
prevalent classes of alternative polyadenylation, and
are involved in regulating 3′ UTRs length and coupling
between alternative splicing and polyadenylation, respect-
ively. All (10 out of 10) the PA clusters, which were
randomly selected from the 3′ UTR regions, can be ex-
perimentally validated (Additional files 8 and 9). Similarly,
10 out of 11 novel intronic PA clusters were validated
(Additional files 8 and 10). For the one case that failed the
initial validation, it was due to an unannotated splicing
event: the PA site was ultimately confirmed with a primerFigure 3 Validation of PA clusters in 3′ UTR and intron regions. (a) A
ITBG5 locus. The primer pair used for validation is shown as arrowheads. (b
in together with a junction primer (sequence-specific sequence + poly(T)) o
amplification product with the correct size is indicated. (c) Validation of a n
was employed as before. Two primer pairs (green and orange) were design
upstream primers. (d) The RT-PCR results produced by two different primer
than expected size, was detected.further upstream and the RT-PCR product is shorter than
the expected size (Figure 3c,d).
Sequence motifs involved in precise PA site selection
Motif analyses were then performed for the PA clusters
identified above. As expected [14,23], AATAAA and
ATTAAA are the top motifs overrepresented in the PA
surrounding regions (Figure 4a). For both annotated and
novel PA clusters, AU-rich and U/GU-rich regions are
detected at upstream and downstream of PA cleavage
site, respectively (Figure 4b,c), which agreed with the
position of canonical poly(A) signal and downstream
sequence element (DSE) in metazoans [5].
It has been shown that PA clusters may vary significantly
in size and shape [19]. We therefore broadly categorized
PA clusters into 3 groups: Narrow Peak (NP), Broad withschematic view of a novel PA site identified in the 3′ UTR region of the
) The results of RT-PCR reactions performed using an upstream primer
r a control primer (only the sequences-specific portion). The
ovel intronic PA site at the PRLP1 locus. The same validation strategy
ed, which use the same downstream junction primer but different
pairs (top: orange; bottom: green). A 550bp band, which is shorter
Figure 4 (See legend on next page.)
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Figure 4 Motif and information content analysis of all identified PA clusters. (a) 6-mer sequence motifs enriched in the region surrounding
PA clusters. The raw data from all 13 tissues were combined for PA cluster calling. The sequence from 50 nt upstream and downstream of PA
clusters was extracted for motif analysis. The information contents of nucleotide sequences surrounding known and novel PA clusters are shown
in (b) and (c), respectively. The zero position is the mode of PA clusters. (d) Histogram of sequence motifs enriched in NP/BP and WP PA clusters.
HOMER was first used to identify 6-mer motifs enriched in 100-bp regions surrounding NP/BP and WP clusters. The frequency of each enriched
motif (p value < 1 × 10-5) is shown by evenly dividing the 100 bp into 100 bins (X-axis), with 0 denotes the mode of the cluster.
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dominant peak (mode ± 2bp > 50% of total reads), whereas
WP exhibits a more dispersed pattern of cleavage sites
(see Methods for detail). Strikingly, majority of the PA
clusters belong to the NP (17,183 clusters or 45.1%) and
BP (16,257 clusters or 42.7%) categories. WP clusters
(4,640 clusters) only account for a small percentage
(12.2%) of all PA clusters. This is in sharp contrast to tran-
scription initiation clusters where WP is the dominant
class [34]. We speculated that the precision in PA site
selection might be achieved by sequence conservation of
cis-acting elements (e.g. PA signal) and/or tight regulation
of polyadenylation machinery.
Next we compared the local sequence content between
focused (NP and BP) and dispersed (WP) polyadenylation
clusters. Interestingly, the distribution of A(A/T)TAAA
motif is much tighter for the peaked (NP/BP) PA clusters
than that of dispersed clusters (WP) (Figure 4d, top 2
panels), suggesting that the broad PA cleavage patterns
may be resulting from multiple closely spaced poly-
adenylation signals. In addition, the sequences down-
stream of PA cleavage site differ significantly between
NP/BP and WP clusters. For NP/BP clusters, they tend
to have an extended G-rich region compared to the
background (intergenic regions), whereas the U-rich
region (‘TTTTTT’ at DNA level) is rather restricted to
immediate sequences downstream of the cleavage site
(Figure 4d, bottom panels). These results are consistent
with notion that PA cleavage sites are often followed by U/
GU-rich (DSE: downstream sequence element) and G-rich
sequences (Auxiliary DSE), which are bound by CstF and
CFIIm, respectively [5]. In contrast, WP clusters tend to
have an extended U-rich downstream of cleave site with a
narrow G-rich region at nucleotide 34–38 positions
(Figure 4d). Two additional motifs, ‘UGUA’ and ‘UGUG’,
were also analyzed. Consistent with the previous report
[40], our results showed that for both NP/BP and WP
clusters these two motifs are enriched at the upstream and
downstream regions of PA cleavage sites, respectively
(Additional file 11). Together, these data suggested that in-
trinsic sequence motifs might play an important role in de-
termining the precision of polyadenylation cleavage events.
Identification of PA signature in diverse tissues
We next aimed to identify PA clusters that exhibit tissue-
specific or tissue-enriched usage. An “entropy” term (H)was introduced to reflect PA site usage among diverse tis-
sues [40]. For PA clusters showing low entropy, the corre-
sponding tissue(s) with dominant PA usage were
subsequently determined (Figure 5, see Methods for de-
tail). As expected, fetal and adult brains share many tissue-
specific PA clusters. Similar findings were also observed
for skeletal muscle and heart. In addition, we examined
whether tissue identity can be inferred from PA site usages.
Starting from the host genes in which the tissue-specific PA
clusters resides, the correct tissues always came out at the
top with the most significant p value (9E-3 to 5E-91,
Figure 5). Since the classification analysis was performed
without the prior inputs on tissue origin, these results
strongly suggest that PA usage, similar to gene expression
profiles, also exhibits tissue-specific signatures.
Tissue specific PA sites are not necessarily resulting
from tissue-specific APA. Several other mechanisms,
such as tissue-specific transcription and/or alternative
splicing, may lead to PA sites with preferential tissue
usage. To determine the potential contribution at the
transcriptional level, tissue-specific PA sites were used to
compile their host transcripts, the promoter regions of
which were subsequently searched for overrepresented
sequence motifs. Interestingly, several transcription
factor-binding sites were identified, which are known to
promote tissue-specific gene expression (Figure 5, right
panel). For instance, the steroidogenic factor 1 (SF1) is
enriched in transcripts with testis-specific PA clusters.
SF1 has recently been shown to cooperate with Sry to
initiate testis development from early bipotential gonads
[41]. It is worth noting that tissue-restricted expression
is not the sole contributor of tissue-specific PA usage.
3′ UTR shortening and gene expression regulation
Alternative polyadenylation (APA) is an important
mechanism for regulated eukaryotic gene expression. It
has been proposed that transcriptional activity is coupled
with APA [42], and highly expressed loci tend to have
shortened 3′ UTR by favoring the proximal APA sites
[18]. These earlier studies arbitrarily divided the 3′ UTR
into “constant” and “alternative” regions based on prior
APA annotations, and the shortening of 3′ UTR was
inferred from microarray or RNA-seq data. Since our
data contain experimentally defined PA sites as well as
their counts, it provides a unique opportunity to interro-
gate global 3′ UTR patterning among different tissues.
Figure 5 Hierarchical clustering of identified tissue specific polyadenylation. Two-way hierarchical clustering of 1966 tissue-enriched
polyadenylation sites was performed based on Pearson correlation and the average linkage method. Normalized tag counts of individual PA
clusters among 13 tissues were log2 transformed and shown as a heatmap. For each set of tissue-enriched PA clusters, tissue-specific transcriptional
factor binding sites overrepresented in the promoter regions of the corresponding genes are shown on the right panel. Similarly, for genes that show
tissue-restricted polyadenylation pattern, they are significantly enriched in the corresponding tissue (p values are shown at the bottom).
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(USI). Based on a consolidated gene model, the USI
analysis employed both the locations and the tag counts
of the PA clusters identified in the 3′ UTR of each tran-
scribed locus (Figure 6a). This is a significant improve-
ment over the previous strategies [18,24,29], which only
considered the most proximal and distal PA sites anno-
tated for individual gene loci. In addition, the expression
level of each gene was approximated by the combined
counts of all PA clusters. Since protein-coding genes
may differ significantly in their transcript structures
(e.g. 3′ UTR length, number of PA sites), we developed
a gene-centric ranking scheme for subsequent analysis.
For each gene in a given tissue, its effective 3′ UTR
length and normalized expression level were ranked with
respect to other tissues, therefore avoiding unexpected
complications due to averaging UTR lengths among
genes (Figure 6b).
Three distinct enrichment patterns were discovered
among tissues examined. Brain, testis, lung and breast
are enriched for genes with abundant transcripts and
a shortened 3′ UTR (Figure 6b middle panel and
Additional file 12 middle panel), while low-abundance
transcripts in several other tissues (e.g. heart, skeletal
muscle) tend to have a lengthened 3′ UTR (Figure 6b top
panel and Additional file 12 top panel). The rest of tissues
(e.g., pancreas and spleen) are by virtue an admixture and
favor both gene categories (Figure 6b bottom panel and
Additional file 12 bottom panel). Despite the tissue prefer-
ences in 3′ UTR shortening/lengthening, these observa-
tions supported the notion of reverse correlation between
3′ UTR length and expression level, indicating the poten-
tial coordination between transcriptional control andalternative polyadenylation [18]. Other possibilities may
also exist; for instance, 3′ UTR length might affect mRNA
stability, a potential mechanism does not necessarily in-
volve transcription regulation.
It has been proposed that 3′ UTR shortening may pro-
mote gene expression, possibly by avoiding miRNA
targeting [43,44]. Conversely, transcripts with longer 3′
UTR are more likely to be targeted by miRNAs and/or
other regulatory molecules. With regard to APA, two
different paradigms might be involved to help establish
tissue identities. The preferential usage of proximal PA
sites in tissue-enriched genes (e.g. brain and testis) is
expected to reinforce transcriptional decision on genes
required for proper tissue functions. Supporting this no-
tion, Gene Ontology (GO) analysis of genes with high
expression rank and shortened 3′ UTR in adult and fetal
brain shows significant enrichment of neural functions
(Additional file 13 and Additional file 14). One interest-
ing example is SNCA, which encodes α-synuclein (non
A4 component of amyloid precursor) and is involved in
the regulation of dopamine release and transport [45].
SNCA is highly expressed in adult and fetal brain com-
pared to other tissue analyzed. In addition, it utilizes a
proximal PA site only in the two brain tissues examined,
while the distal PA site is employed in other tissues (e.g.
pancreas and testis, Figure 6c). These data supported the
notion that APA might play important roles in
establishing tissue or cell identity. In contrast, certain
lowly expressed transcripts might be the result of leaky
transcription and 3′ UTR lengthening of these tran-
scripts may help prevent their expression at the post-
transcriptional level. It is worth noting that the two
above mechanisms are not mutually exclusive. As
Figure 6 Tissue preference of 3′ UTR shortening/lengthening. (a) A schematic diagram for computing 3′ UTR shortening index (USI). Ci is the tag
counts of corresponding PA cluster while Li denotes the length of corresponding PA cluster. (b) For each given tissue, the relative expression level
(X-axis) and 3′ UTR length (Y-axis) of individual genes were ranked among 13 tissues. Each box in a given 2D plot represents a specific subset of genes
grouped by their ranks. The color of each box represents enrichment (Red) or depletion (Blue) of the corresponding gene group. Upper panel: two
tissues (skeletal muscle and heart) enriched for genes with lower expression rank and longer 3′ UTR; Middle panel: overrepresentation of genes with
higher expression rank and shorter 3′ UTR in adult and fetal brain; Bottom panel, both lowly expressed genes with longer 3′ UTR and highly expressed
genes with shorter 3′ UTR are enriched in pancreas and spleen. (c) α-synuclein coding gene SNCA shows higher expression rank and shortened
effective 3′ UTR in both adult and fetal brain tissues. Normalized tag number is represented in Y-axis. Known RefSeq transcripts are shown at
the bottom.
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bottom panel), they might complement each other to en-
sure a broader genome-wide coordination.Discussion
To profile global polyadenylation events, several sequen-
cing based methods have been developed [19,25,28,30].
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a stretch of repetitive sequence introduced by oligo(dT)
priming. Due to low sequence complexity downstream of
the PA cleavage sites of interest, such experimental design
often led to unnecessary challenges at the sequencing step
(requiring long sequence read if sequenced from 5′ end or
using oligo(dT) as sequencing primer, which might not be
optimal, if sequenced from 3′ end). To solve this problem,
our PA-seq strategy introduced a modified base (dUTP)
in the oligo(dT), which can help remove the stretch of
‘T’ by Uracil-Specific Excision Reagent (USER) after second
strand synthesis, and thus enables direct interrogation of
polyadenylation sites in a more effective manner. Although
our PA libraries can be sequenced directly from the 3′ end,
paired-end sequencing was employed in this study, which
is expected to further improve mapping specificity and
efficiency as well as recapitulate local sequence complexity
(e.g. splicing events in the 3′ UTR region). A detailed
comparison between the PolyA-seq [27] and PA-seq (this
study) in mappability and identification of PA sites can
be found in Additional file 15 and Additional file 16,
respectively.
Another innovative polyadenylation method, 3P-Seq,
has also been developed [29]. One major advantage of
this method is the use of splint oligo ligation to avoid in-
ternal priming events. In addition, it employed RNase H
digestion to shorten poly(A) tail of the target mRNAs.
However, the PA profiles resulting from 3P-Seq strategy
is not as quantitative as conventional methods, possibly
due to the involvement of multiple ligation steps that
may not be highly efficient [27]. An alternative approach,
3′READS, has also been developed to address the in-
ternal priming issue [46]. These methods can be used to
generate a reference list of authentic PA sites, which can
help further improve the computational strategy of our
PA-seq analysis to achieve more reliable and quantitative
profiling of genome-wide polyadenylation events.
Alternative polyadenylation is known to be an import-
ant mechanism in regulating tissue-specific gene expres-
sion and proteome diversity. One striking observation
from this study is the distinct tissue preference in 3′
UTR shortening/lengthening. Since our analyses focused
on tandem PA sites in the 3′ UTR region, it is unlikely
that 3′ UTR shortening/lengthening is a direct result of
alternative splicing. However, it does not rule out that
splicing factors, in addition to other RNA binding pro-
teins, may play a direct role in controlling PA choices.
An early profiling study has identified the expression sig-
nature of splicing factors in different tissues; and snRNP
(small nuclear ribonucleoprotein particle) is among
the splicing factor genes that are highly differentially
expressed particular in brain and testis [47]. Accumulated
evidence showed that U1 snRNP plays a determinative
role in regulating polyadenylation and mRNA length[24,48]. Therefore, it will be of great interest to further
characterize the direct involvement of component of
basal and alternative splicing machinery in regulated
polyadenylation.
Strikingly, we found selective 3′ UTR shortening in
genes highly expressed in fetal and adult brain, while
others have found that brain transcripts on average have
the longest 3′ UTR in length [32], a subset of which may
even have extended 3′ UTR beyond current annotations
[49]. Instead of averaging among transcribed loci, our ana-
lysis is a gene-centric approach, comparing the normalized
expression level as well as the effective UTR length of the
same gene among diverse tissues, to uncover potential co-
ordination between gene expression and polyadenylation.
These opposing observations may not be contradictory as
they seem to be at the initial glimpse. Together, these data
implied that a subset of brain-enriched genes preferen-
tially shorten their 3′ UTRs to ensure a high level of ex-
pression, despite that a different subset of transcripts
expressed in the brain may have a rather extended 3′
UTR. As one prevalent phenomenon in neurons, it has
been shown that brain-enriched miRNAs tend to co-
express with their target genes, which also exhibit brain-
specific expression [50]. The paradox can be in part
explained by selective 3′ UTR shortening and target
avoidance, suggesting alternative polyadenylation might be
critical for establishing neuronal cell identity.
Lastly, we found ncRNA, similar to protein coding
transcripts, are also extensively regulated at the poly-
adenylation level. The data sets presented here provided
a starting point to further characterize the functional
significance of such regulatory events. It is plausible that
different ncRNA isoforms may have distinct regulatory
functions, cellular localization and/or stability. For in-
stance, comparison of polyadenylation transcripts at dif-
ferent cellular compartments is expected to interrogate
potential links between alternative polyadenylation and
subcellular localization. Further integration of function
and interaction data (e.g. the secondary structure of
noncoding transcripts with or without alternative region)
is required for to characterizing this additional level of
transcriptome complexity and deserves future study.
Conclusions
One major challenge of profiling transcriptome 3′ end is
to avoid sequencing the poly(A) stretch. We used
Uracil-Specific Excision Reagent to recognize and cleave
the modified base (dUTP) near the polyadenylation site,
therefore eliminating the potential complication due to
these low complexity sequences. Using this modified
PA-seq strategy, tissue-specific PA signatures were iden-
tified. Furthermore, we showed that noncoding tran-
scripts, similar to protein-coding genes, are extensively
regulated at the 3′ end. In addition, downstream G-rich
Ni et al. BMC Genomics 2013, 14:615 Page 11 of 15
http://www.biomedcentral.com/1471-2164/14/615motif and upstream U-rich motif played an important
role in the regulation of tissue-specific polyadenylation.
Lastly, we showed distinct patterns of 3′ UTR shortening/
lengthening among different tissues, which suggested that
APA may play a critical role in establishing tissue or cell
identity. Together, the PA-seq strategy provided a compre-




Total RNA derived from 13 normal human tissues, in-
cluding adult brain, fetal brain, kidney, liver, prostate,
testis, breast, colon, heart, lung, pancreas, spleen and
skeletal muscle were purchased from Biochain or
Clontech. 10 μg of DNA-free total RNA was sheared
into 200–300 nt fragments by heating (94°C for 3 mi-
nutes) with magnesium. Sheared RNA was precipitated
by ethanol with GlycoBlue (Ambion) as a carrier. Re-
verse transcription was carried out using a modified
oligo(dT) primer (5′-bio-TTTTTTTTTTTTTTTTdUT
TTVN-3′, ‘bio’ denotes duo biotin group, ‘dU’ stands for
deoxyuricile, ‘V’ represents any nucleotide except T and
‘N’ denotes any nucleotide). Incubate the reverse tran-
scription reaction at 42°C for 2 min before adding
Superscript reverse transcriptase II (Invitrogen) to in-
crease specificity. After second strand synthesis,
Dynabeads MyOne C1 (Invitrogen) was used to pull
down the resulting dsDNA. Incubate the beads with
APex Heat-Labile Alkaline Phosphatase (Epicentre) to
remove phosphate group, which enables strand specifi-
city at the later PCR step since only the bottom strand
cDNA can be ligated and thus amplified. To release
dsDNA from MyOne beads, USER enzyme (NEB) was
added. The released dsDNA was then end repaired,
followed by adding an ‘A’ base at the ends. Illumina
paired-end Y linker was ligated and size selected. A 16-
cycle PCR was then carried out with Phusion Hot Start
High-Fidelity DNA Polymerase (Finnzymes) to generate
the final PA-seq libraries, which were sequenced using
Illumina HiSeq2000 platform.
Paired-end mapping
Paired-end reads were split into 13 tissue samples by
barcode and further correct the strand according to
‘TTT’ at the beginning of the reads. Processed raw data
were then aligned by bwa [51] to human genome (ver-
sion hg19) allowing two mismatches and processed by
samtools [52]. All uniquely mapped pairs were used for
downstream analyses.
Comparison of PA-seq data with PolyA_DB and RefSeq
PolyA_DB (version 1, only contain human and mouse
poly(A) sites) was downloaded from Bin Tian’s website(http://exon.umdnj.edu/polya_db/) [14]. PolyA_DB data
was collected from all cDNA/ESTs sequences in the
UniGene database from NCBI (July and August 2005
version) and aligned to genome sequences build hg17
using BLAT. ESTs sequences came from a variety of tis-
sues including eye, retina, skin, testis, pancreas, stomach,
colon, brain and mixed tissues. For PolyA_DB se-
quences, coding and intronic regions were taken into
consideration for those falling in 3′ UTR with 1kb up-
stream and 1kb downstream. For PA-seq data, we se-
lected those pairs with more than one unique 5′ reads.
Since in PolyA_DB, each gene has at least one poly(A)
site, some genes actually appear more than once, and
hence the minimum distance varies accordingly. For
comparison with RefSeq annotation, we download the
database from UCSC. Both protein-coding and non-
coding genes were computed. All mappable pairs and
non-redundant pairs were calculated separately.
Peak calling and cluster analysis
After mapping, the information of exact cleavage and
polyadenylation sites was extracted. F-seq [35] was used
for the peak calling of PA sites. The PA-seq data from
13 tissues were combined so that a unified peak-calling
scheme can be applied. We resized the PA clusters to
the shortest distance that contained 95% of the reads
according to our previous publication [34]. To filter in-
ternal priming, we removed PA clusters with 15 ‘A’ in
the 20 nucleotides region downstream of peak mode.
With a minimum of 50 tags, we classified the PA clus-
ters into three patterns by the following definitions [34]:
Narrow Peak (NP) clusters contained ≥ 50% of the reads
within ±2 nt of the mode and span < 10 nt; Broad with
Peak (BP) clusters were those that contained ≥ 50% of
the reads within ±2 nt of the mode and are ≥ 10 nt in
length; All other clusters were classified as Weak Peak
(WP). RefSeq annotation was used for the genomic loca-
tion analysis. For peaks falling into multiple categories,
we set priority as PA > 3′-UTR > Extended_3′-UTR >
Exon > Intron > 5′-UTR > TSS > Promoter. PA defined as
annotated PA site plus upstream and downstream 10bp.
Extended_3′-UTR denotes downstream 1 kb of 3′ UTR.
TSS represents exact transcriptional start site plus up-
stream and downstream 10bp. Promoter defined as up-
stream 250 bp of TSS. For Figure 4d, we applied 5 bp
window as threshold of NP and BP.
Motif and information content analysis
Homer software from UCSD (http://biowhat.ucsd.edu/
homer/) was used to perform the motif analysis in
Figure 4d and Additional file 11. 6mer motifs were ana-
lyzed. Weblogo version 3 (http://weblogo.threeplusone.
com) was used to draw the information content with clas-
sic color scheme for Figure 4b,c. Top four enriched 6mer
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surrounding NP/BP and WP PA clusters separately. 4000
random intergenic sequences each with 100 bp in length
were also scanned by top four enriched 6mer motifs. The
frequency of each enriched motif was calculated by nor-
malizing total input sequences.
Shannon entropy analysis of tissue-specific polyadenylation
Shannon entropy [40] was used for the analysis of identi-
fying tissue-specific polyadenylation sites. First, we nor-
malized each tissue PA-seq data by its library size, and
then performed quantile normalization for all 13 tissues
PA-seq data. Shannon entropy score H was computed
for each polyadenylation site. Q scores were computed
based on H score to estimate the expression specificity
of each PA site for a particular tissue. Based on H and Q
scores’ distribution and variation, we applied the cut-off
corresponding approximately less than the median
minus two standard deviations to identify the regulated
tissue specific polyadenylation sites. On the contrary, we
detected constitutive PA sites when both H and Q values
are greater than mean plus two standard deviations.
Clustering of tissue specific gene expression
Unsupervised two-way hierarchical clustering of 13 tis-
sues and identified tissue specific polyadenylation sites
was performed based on Pearson correlation and the
average linkage method. In each specific tissue cluster,
1kb upstream sequences from PA cluster start site were
scanned for finding transcription factor (TF) binding
sites common to at least 60% of input sequences by
MatInspector in Genomatix Genome Analyzer. Tissue-
specific TFs were selected by p value < 10-7.
Gene ontology analysis
DAVID (Database for Annotation, Visualization and
Integrated Discovery) [53] was used for the GO ana-
lysis of enriched genes from Figure 6b. Three terms
(GOTERM_BP_FAT, GOTERM_CC_FAT and GOTERM_
MF_FAT) were selected for analysis. The top ten GO
terms in the “Functional Annotation Chart” were shown
in Additional file 13 and Additional file 14. The default
population background in enrichment calculation consists
of all corresponding genes in the genome that have at least
one annotation in the analyzing categories.
Define 3′ UTR shortening index
We used Entrez gene ID to cluster the RefSeq transcript
IDs. Overlapping genes on the same strand were
removed from further consideration to avoid wrongful
assignment of PA site to 3′ UTR. Furthermore, we
restricted our attention to genes (represented by
Entrez IDs) whose annotated transcripts (represented by
RefSeq IDs) that shared the same stop codon. Basedon the consolidated gene model above, the pipeline
considers both the locations (L) and the tag counts (C)
of the PA clusters identified in the 3′ UTR of each
transcribed locus to compute “Effective_UTR_Length”
(Effective_UTR_Length = Σ(Ci × Li)/ΣCi, see Figure 6a).
3′ UTR shortening index (USI) is defined as the length
difference between annotated and effective 3′ UTR
(USI = Annotated_UTR_Length − Effective_UTR_Length,
see Figure 6a). The effective 3′ UTR length and PA
cluster expression were ranked from low to high separ-
ately among 13 tissues. Each box in a given 2D plot
(Figure 6b) represents Z-score of the observed number
of PA clusters (genes) in the specific tissue.
RT-PCR validation of PA clusters
To validate the mode of a PA cluster, a junction primer
(+, half complementary to 3′ end sequence and half
complementary to poly(A) sequence) together with an
upstream gene-specific primer were designed by Primer3
(version 0.4.0) and synthesized by IDT. The control pri-
mer (−) lacks the sequence complementary to poly(A).
Reverse transcription of 1μg DNA-free total RNA was
performed with SuperScript II reverse transcriptase
(Invitrogen) in a 20 μl reaction, containing 4 pmol oligo
(dT) primer (5′-TTTTTTTTTTTTTTTTTTTTVN-3′),
40 units of RNasin (Promega) and 6 ng/μl freshly-made
actinomycin D. RT reaction was incubated at 42°C for 2
min before adding reverse transcriptase. We then incu-
bate the reaction at 42°C for 60 min and 75°C for 15
min. PCR was performed in a 20 μl reaction, containing
1 μl of RT template, 1× PCR buffer (Qiagen), 0.4 nmol
dNTP, 0.4 pmol of each forward and reverse primer, and
1 μl of Taq DNA Polymerase (Qiagen). Thermal cycling
was carried out as the following: 94°C for 30s; 30 ~ 40
cycles of 94°C for 30s, 52 ~ 58°C for 30s and 72°C for
30s; 72°C for 10 min; hold at 4°C. 3μl of PCR product
was taken out and run in a 2% agarose gel.
Data access
PA-seq raw data can be found at the NCBI Sequence Read
Archive (SRA) with submission number SRA059064. Cus-
tom tracks of 13 tissues can be found in Additional file 17.
Additional information
A step-by-step protocol of PA-seq can be found in
Additional file 18.
Additional files
Additional file 1: Mapping summary of PA-seq paired-end reads.
Additional file 2: Distribution of all PA-seq 3′ reads relative to
annotated RefSeq poly(A) sites. For genes with multiple annotated PA
sites in the RefSeq database, only the longest poly(A) site is included.
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http://www.biomedcentral.com/1471-2164/14/615Additional file 3: Distribution of non-redundant PA-seq 3′ reads
relative to annotated RefSeq poly(A) sites. For genes with multiple
annotated PA sites in RefSeq database, only the longest poly(A) site is
included.
Additional file 4: Expression correlation between Affymetrix array
and PA-seq data. Log2 transformed values of Affymetrix array (X-axis)
and PA-seq reads (Y-axis) in liver are shown. R denotes correlation
coefficient. For PA-seq, total mappable reads were used for expression
comparison.
Additional file 5: Expression correlation between PA-seq and RNA-
seq data. Additional RNA-seq data was obtained for the same human
kidney sample used in the PA-seq analysis. We used total mappable
reads for expression comparison. The expression levels of individual gens
were computed based on RPKM (reads per kb per million) and RPM
(reads per million) for RNA-seq and PA-seq, respectively. a) The
expression correlation between RNA-seq (X-axis) and PA-seq (Y-axis) is
shown as a scatter plot, and all mappable reads in the PA-seq were
included in the analysis. b) is the same as a) except that PA-seq were
further processed to remove sequence reads that are not in the PA
clusters identified.
Additional file 6: Distribution of 7714 distant PA clusters. Distant PA
clusters were categorized into 3 groups, NP, BP and WP, using the same
criteria as genic PA clusters. Briefly, NP (narrow peak) clusters were
defined as ≥ 50% of the reads within ±2 nt of the mode and the cluster
size is < 10 nt; BP (Broad with Peak) clusters were those clusters that
contain ≥ 50% of the reads within ±2 nt of the mode and are ≥ 10 nt in
length; All other clusters were classified as Weak Peak (WP). (see Methods
for detail). The number as well as the percentage of distant PA clusters in
NP, BP and WP categories are shown.
Additional file 7: The usage of PA sites among human tissues. As
a stringent cutoff, a PA cluster (or PA site) is defined as “utilized in a
tissue” only if its tag count is greater than the median tag count
(quantile normalized) of the corresponding tissue. a) The usage of all
PA clusters identified by PA-seq among 13 tissues. For each PA cluster,
we first determined the number of tissues it is utilized, and the overall
distribution of PA usages is shown in a histogram. In summary,
majority (~87%) of the PA clusters can be found in 5 or more tissues
(y-axis) with 35.53% of the clusters were detected in all 13 tissues. In
addition, 13.36% of all PA clusters showed a relatively tissue-restricted
usage in less than 5 tissues. b) The usage of 7714 distant PA
clusters among 13 tissues. The same analysis was performed as a).
Overall, ~90% of the distant PA clusters were employed in 5 or more
tissues (y axis), and 17.92% of the clusters can be detected in all 13
tissues. 10.11% PA clusters showed a relatively tissue-restricted usage
in less than 5 tissues.
Additional file 8: RT-PCR validation of novel PA clusters located in
intronic or intergenic regions. a) A schematic diagram for experimental
validation of PA clusters. A junction primer (+, half complementary to the
region immediately upstream of PA cleavage site and half complementary
to polyA sequence), in together with an upstream gene-specific primer, was
used to validate the corresponding polyA site. A control primer (−), which
contains only the gene-specific portion of the junction primer, served as a
negative control. For an authentic polyA site, the junction primer is
expected to produce a specific band, but the control primer fails to do so
because of its lower melting temperature (Tm). Novel poly(A) sites in 3′ UTR
(b) and intronic (c) region were validated by a junction primer (+, half
complementary to 3′ end sequence and half complementary to polyA
sequence) together with an upstream primer. The control primer (−) lacks
the sequence complementary to poly(A).
Additional file 9: Primer pairs for validation of PA clusters in 3′ UTR.
Additional file 10: Primer pairs for validation of PA clusters in
intronic regions.
Additional file 11: Enrichment of UGUA and UGUG motifs in NP/BP
and WP PA clusters. Two 4-mer motifs, UGUA and UGUG (TGTA and
TGTG at the DNA level were scanned in 100-bp regions surrounding NP/
BP and WP clusters. We evenly divided the 100 bp regions into 20 bins
(X-axis) and the motif frequencies (Y-axis) of individual bins were plotted.
The “0” position denotes the mode of the PA cluster.Additional file 12: Distinct patterns of 3′ UTR shortening/
lengthening in human tissues. Upper panel, genes with lower
expression rank and longer 3′ UTR are enriched in specified tissue (Kidney
and Liver); Middle panel, genes with higher expression rank and shorter
3′ UTR are enriched in specified tissue (Testis, Lung and Breast); Bottom
panel, both lowly expressed genes with longer 3′ UTR and highly
expressed genes with shorter 3′ UTR are enriched in specified tissue
(Pancreas and Colon). X-axis reflects the expression ranking among 13
tissues for each gene. Y-axis denotes the ranking of average 3′ UTR
length. Color bar shows the enrichment of genes in each tissue. Red
denotes enrichment while blue represents depletion.
Additional file 13: GO analysis of genes (top right corner in dashed
square) in Adult Brain.
Additional file 14: GO analysis of genes (top right corner in dashed
square) in Fetal Brain.
Additional file 15: Mapping quality comparison between our data
and data published by Derti et al.
Additional file 16: Comparison of PA peaks identified by PolyA-seq
(Derti) and PA-seq (this study).
Additional file 17: Custom tracks (wiggle format) of PA-seq for
13 human tissues.
Additional file 18: A step-by-step protocol of PA-seq.
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